TMS for Eating Disorders: Anorexia, Bulimia and Binge Eating

TMS is an off-label, research-stage treatment for eating disorders. In anorexia nervosa, a 2026 meta-analysis found no significant gain in body mass index with active TMS compared with sham, and no effect on binge or vomiting frequency across anorexia and bulimia; the clearest benefit was on depressive symptoms. For binge eating disorder, one 2025 randomized trial reported fewer binge episodes, a promising but single result.

No TMS device is FDA-cleared for any eating disorder. For anyone with an eating disorder considering TMS, the more pressing questions are often medical: low weight, purging and electrolyte disturbance all bear directly on seizure risk.

The evidence at a glance

ConditionBest available evidenceCore symptomsMood
Anorexia nervosaSmall sham-controlled trials; 2026 meta-analysisNo significant BMI gain vs shamDepression improved vs sham
Bulimia nervosaSmall trials within the same meta-analysisNo effect on binge or vomiting frequency; urge to eat fellLimited data
Binge eating disorderOne 60-person sham-controlled RCT (2025)Fewer binge episodes; no difference in craving or BMINo group differences reported on other outcomes

Anorexia nervosa

The rationale is that anorexia involves altered reward processing and rigid, overcontrolled decision-making, partly mediated by prefrontal circuits that TMS can reach. Most trials stimulate the left dorsolateral prefrontal cortex, the standard depression target.

The UK TIARA feasibility trial is a good example of the evidence's shape. It randomized 34 adults with severe, enduring anorexia (illness of three years or more and at least one completed treatment) to 20 sessions of MRI-guided high-frequency TMS or sham, added to usual care. Treatment was safe and acceptable. Effects on BMI and eating-disorder symptoms were small, while effects on mood were moderate to large. The authors called for a larger confirmatory trial.

The 2026 meta-analysis by Ewis and colleagues pooled 13 studies with 195 active and 132 sham treatments. Body mass index did not change significantly compared with sham, while depression scores did. One unexpected signal: the urge to eat increased in anorexia after TMS, a result from only 30 patients whose clinical meaning is unclear.

Bulimia nervosa

Bulimia trials are fewer and smaller. Pooled data show no effect on binge or vomiting frequency, the behaviors that define the illness and drive its medical risk. Self-reported urge to eat fell in a pooled sample of 25 patients with bulimia. A separate 2026 review of noninvasive brain stimulation in bulimia and binge eating disorder concluded that current evidence "does not support a clinically meaningful benefit" for core symptoms and that use should be considered investigational.

Binge eating disorder

The most encouraging single study is in binge eating disorder. A double-blind trial randomized 60 people with binge eating disorder and obesity to 20 sessions of neuronavigated 10 Hz TMS to the left DLPFC or sham. The active group had a greater reduction in binge episodes at the end of treatment and at a later follow-up, but no group differences in craving, BMI or other outcomes. It is one trial; replication is the next step. Medication options for binge eating, including the evidence on GLP-1 drugs, are reviewed in GLP-1 medications for binge eating disorder.

Medical safety: why eating disorders change the seizure question

Seizure is the most serious acute risk of TMS. It is rare under standard protocols, but risk rises with factors that lower the seizure threshold. Several of those factors are common in eating disorders.

  • Electrolyte disturbance. FDA device guidance asks for close monitoring of patients with conditions that alter electrolyte balance, and the IFCN safety guideline lists low sodium, calcium and magnesium as threshold-lowering factors. Vomiting, laxative and diuretic misuse, and water loading all disturb electrolytes, sometimes from day to day.
  • Low or unstable blood sugar. Both low and high blood glucose appear on the IFCN list. Fasting before sessions is a practical concern.
  • Sleep deprivation, stimulants such as cocaine or MDMA, and alcohol withdrawal, all of which the IFCN guideline names, can accompany restrictive or binge-purge illness.
  • Seizure risk is highest in the first few sessions, so medical stability needs to be in place before starting, not established along the way.

In practice, anyone with an active eating disorder who is being considered for TMS needs recent labs, including electrolytes and glucose, a weight and vital-sign check, and coordination with the eating disorder team. These steps are part of the broader medical workup before TMS; the seizure data are in TMS safety and seizure risk.

Depression alongside an eating disorder

Depression frequently accompanies eating disorders, and it is the one outcome where TMS trials in this group show a consistent signal. Depression is also a cleared indication in its own right. For someone in recovery, medically stable, whose depression has not responded to antidepressants, TMS for depression may be reasonable.

Coverage can be a hurdle. Some behavioral health managers ask clinicians to attest that the patient has had no active eating disorder in the past year before approving TMS for depression. That reflects payer caution, not a medical prohibition, but it shapes timing. Payer-specific criteria are in the Aetna and other coverage guides in this hub.

Suicide risk needs active attention in anyone with an eating disorder, particularly when depression is also present. If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.

Why the evidence is still thin

Eating disorder trials of TMS face problems that depression trials do not. Participants are often medically fragile, which limits who can enroll and how many sessions they can attend. Weight restoration takes months, while most TMS trials measure outcomes within weeks. Binge and purge frequency fluctuates with stress and life events, so small samples produce noisy results. Studies also differ in target, frequency, number of sessions and whether TMS is added to intensive treatment or given alone.

The result is a literature in which a promising signal in one small study is often not confirmed in the next. The most useful next step would be larger, sham-controlled trials with follow-up long enough to capture weight and behavior, which is what the TIARA investigators recommended.

What treatment should look like first

The foundations of eating disorder care have far stronger evidence than any brain stimulation approach: medical monitoring and nutritional rehabilitation, eating-disorder-focused psychotherapy (including CBT for eating disorders and, for adolescents, family-based treatment), and medication where it has a role, such as for binge eating disorder or co-occurring depression. The site's eating disorders and CBT for eating disorders pages describe that approach.

Where TMS research fits is in the hardest cases, such as severe, enduring anorexia that has not responded to repeated treatment, and that is where trials are concentrated. Anyone in that situation is best served by a registered trial with an experienced eating disorder team, not a standalone TMS course. A similar pattern, real effects on craving that have not yet translated into behavior change, appears in TMS for addiction.

Questions to ask before trying TMS

  1. Is the target the eating disorder itself (off-label, research-stage) or co-occurring depression (a cleared use)?
  2. Are my electrolytes, glucose and weight stable, and who will check them during the course?
  3. Is my eating disorder team involved in the decision?
  4. What outcome will we track, and over what time frame?
  5. Is there a clinical trial I could join instead?

For an overview of how TMS works and what it is cleared for, start with the TMS guide or the TMS overview.

Frequently asked questions

Can TMS help with anorexia weight restoration?

Not on current evidence. A 2026 meta-analysis found no significant gain in BMI with active TMS compared with sham. Mood improved more consistently than eating-disorder symptoms.

Does TMS stop bingeing or purging?

Pooled trials in anorexia and bulimia showed no effect on binge or vomiting frequency. One 2025 trial in binge eating disorder found fewer binge episodes, which needs replication.

Is TMS safe if I purge or restrict?

It needs extra care. Electrolyte imbalance and low blood sugar lower the seizure threshold, so labs, weight and vital signs should be stable and checked before and during any course.

Can I have TMS for depression if I have a history of an eating disorder?

Often yes, if you are medically stable and the depression meets the usual criteria. Some insurers ask for no active eating disorder in the past year, which can affect timing.

Is TMS FDA-cleared for eating disorders?

No. Any TMS aimed at anorexia, bulimia or binge eating disorder is off-label and best done within a clinical trial.

Sources

  1. Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clinical Neurophysiology, 2021. europepmc.org
  2. Seizures from transcranial magnetic stimulation 2012-2016: Results of a survey of active laboratories and clinics. Clinical Neurophysiology, 2019. europepmc.org
  3. Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation (rTMS) Systems. U.S. FDA, 2011. fda.gov
  4. Efficacy and safety of repetitive transcranial magnetic stimulation in anorexia and bulimia nervosa: a systematic review and meta-analysis. Annals of General Psychiatry, 2026. europepmc.org
  5. Carelon Behavioral Health Repetitive Transcranial Magnetic Stimulation Request Form (commercial contracts). Carelon Behavioral Health, 2026. carelonbehavioralhealth.com
  6. Randomised controlled feasibility trial of real versus sham repetitive transcranial magnetic stimulation treatment in adults with severe and enduring anorexia nervosa: the TIARA study. BMJ Open, 2018. europepmc.org
  7. Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in binge eating disorder: a double-blind randomized controlled trial. Psychological Medicine, 2025. europepmc.org
  8. Non-invasive brain stimulation as an experimental treatment approach for bulimia nervosa and binge eating disorders: A meta-analysis and systematic review of literature. Indian Journal of Psychiatry, 2026. europepmc.org

Educational information, not medical advice. Whether TMS or any treatment fits you is a decision to make with a psychiatrist who knows your history.

Disclaimer
The information provided on this blog is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.